Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Magnetic Resonance Imaging

• Publication date

  2008-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.mri.2008.01.012PMID 18486387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.

  2008cited by this paper
• Differential Effects of Antipsychotic and Glutamatergic Agents on the phMRI Response to Phencyclidine

  2008influential reference
• Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.

  2007cited by this paper
• A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI.

  2007cited by this paper
• Region‐specific effects of a tyrosine‐free amino acid mixture on amphetamine‐induced changes in BOLD fMRI signal in the rat brain

  2007cited by this paper
• In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI

  2007cited by this paper
• Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI.

  2007cited by this paper
• A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI

  2006influential reference
• Region-Specific Effects of Nicotine on Brain Activity: A Pharmacological MRI Study in the Drug-Naïve Rat

  2006cited by this paper
• Mapping the central effects of ketamine in the rat using pharmacological MRI

  2006cited by this paper
• Anaesthetic drugs: linking molecular actions to clinical effects.

  2006cited by this paper
• A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: Application to pharmacological MRI

  2006cited by this paper
• Mapping the central effects of ketamine in the rat using pharmacological MRI

  2006cited by this paper
• Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling

  2006cited by this paper
• The role of fMRI in drug discovery

  2006cited by this paper
• Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats.

  2005cited by this paper
• Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain

  2005cited by this paper
• Methodological considerations in rat brain BOLD contrast pharmacological MRI

  2005cited by this paper
• PCP: from pharmacology to modelling schizophrenia.

  2005cited by this paper
• Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI.

  2005cited by this paper
• Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

  2005cited by this paper
• Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI

  2005cited by this paper
• Selective dopamine D3 receptor antagonist SB‐277011‐A potentiates phMRI response to acute amphetamine challenge in the rat brain

  2004cited by this paper
• Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration

  2004cited by this paper
• High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats

  2004cited by this paper
• Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course.

  2003cited by this paper
• The NMDA Receptor Hypofunction Model of Psychosis

  2003cited by this paper
• Effects of Subanesthetic Doses of Ketamine on Regional Cerebral Blood Flow, Oxygen Consumption, and Blood Volume in Humans

  2003cited by this paper
• Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.

  2002cited by this paper
• Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia †

  2001cited by this paper
• A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia

  2001cited by this paper
• Effects of Ketamine in Normal and Schizophrenic Volunteers

  2001cited by this paper
• Effects of Ketamine, MK-801, and Amphetamine on Regional Brain 2-Deoxyglucose Uptake in Freely Moving Mice

  2000cited by this paper
• Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.

  2000cited by this paper
• Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension.

  1999cited by this paper
• Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia.

  1999cited by this paper
• Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

  1999cited by this paper
• Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.

  1999cited by this paper
• Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

  1998cited by this paper
• Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation

  1998cited by this paper
• Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

  1998cited by this paper
• Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data

  1997cited by this paper
• Analysis of functional MRI time‐series

  1994cited by this paper
• A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain

  1992cited by this paper
• Halothane enhances tonic neuronal inhibition by elevating intracellular calcium.

  1991cited by this paper
• Alterations in local cerebral glucose utilization induced by phencyclidine.

  1987cited by this paper
• Ketamine Effects on Local Cerebral Blood Flow and Metabolism in the Rat

  1987cited by this paper
• NEUROBIOLOGY OF PHENCYCLIDINE (SERNYL), A DRUG WITH AN UNUSUAL SPECTRUM OF PHARMACOLOGICAL ACTIVITY.

  1964cited by this paper

• Charting the path in rodent functional neuroimaging

  2025cites this paper
• Pharmacological MRI: Utility in Understanding Drug Mechanisms in Psychiatric Disorders

  2025cites this paper
• The history and future of resting-state functional magnetic resonance imaging

  2025cites this paper
• A novel low-rank reconstruction framework for precise fat-tumor discrimination in diffusion-weighted MRI

  2024cites this paper
• Mapping and comparing fMRI connectivity networks across species

  2023cites this paper
• Where do we stand on fMRI in awake mice?

  2023cites this paper
• Modeling Brain Dysconnectivity in Rodents.

  2022cites this paper
• Unique spatiotemporal fMRI dynamics in the awake mouse brain

  2021cites this paper
• Anterior insula stimulation suppresses appetitive behavior while inducing forebrain activation in alcohol-preferring rats

  2020cites this paper
• The M1/M4 agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain

  2020cites this paper
• The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain

  2020cites this paper
• Segmented Echo Planar Imaging Improves Detection of Subcortical Functional Connectivity Networks in the Rat Brain

  2019cites this paper
• Aberrant insular cortex connectivity in abstinent alcohol‐dependent rats is reversed by dopamine D3 receptor blockade

  2019cites this paper
• Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior

  2018cites this paper
• phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol‐preferring from genetically heterogenous rats

  2018cites this paper
• Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate

  2017cites this paper
• Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for studying brain chemistry

  2017cites this paper
• Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates

  2017cites this paper
• The effect of NMDA‐R antagonism on simultaneously acquired local field potentials and tissue oxygen levels in the brains of freely‐moving rats

  2017cites this paper
• Enhanced limbic/impaired cortical‐loop connection onto the hippocampus of NHE rats: Application of resting‐state functional connectivity in a preclinical ADHD model

  2017cites this paper
• Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action

  2017cites this paper
• Functional networks and network perturbations in rodents

  2017cites this paper
• Detecting dopamine dysfunction with pharmacological MRI

  2016cites this paper
• Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate

  2016cites this paper
• Rodent Models of Stroke

  2016cites this paper
• Biological function of D-aspartate in the mammalian brain

  2016cites this paper
• A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

  2015cites this paper
• A systematic review of physiological methods in rodent pharmacological MRI studies

  2015cites this paper
• Distributed BOLD and CBV-weighted resting-state networks in the mouse brain

  2014cites this paper
• Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study

  2014cites this paper
• Dysfunctional dopaminergic neurotransmission in asocial BTBR mice

  2014cites this paper
• Investigation of Cross-Species Translatability of Pharmacological MRI in Awake Nonhuman Primate - A Buprenorphine Challenge Study

  2014cites this paper
• Impaired Limbic Cortico-Striatal Structure and Sustained Visual Attention in a Rodent Model of Schizophrenia

  2014cites this paper
• In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.

  2014cites this paper
• Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat

  2014cites this paper
• Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine

  2013cites this paper
• Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers

  2013cites this paper
• A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging.

  2013cites this paper
• A robust experimental protocol for pharmacological fMRI in rats and mice.

  2012cites this paper
• Neuroimaging as a Translational Tool in Animal and Human Models of Schizophrenia

  2012cites this paper
• Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics

  2012cites this paper
• Modulation of Fronto-Cortical Activity by Modafinil: A Functional Imaging and Fos Study in the Rat

  2012influential citation
• Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

  2012cites this paper
• The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation.

  2012cites this paper
• Probing brain function with pharmacological MRI

  2011influential citation
• The Efficacy of Sodium Channel Blockers to Prevent Phencyclidine-Induced Cognitive Dysfunction in the Rat: Potential for Novel Treatments for Schizophrenia

  2011cites this paper
• Applications of MRI to Psychopharmacology

  2011cites this paper
• Functional and pharmacological MRI in understanding brain function at a systems level.

  2011cites this paper
• Metadata of the chapter that will be visualized online

  2010cites this paper
• Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

  2010cites this paper
• Noninvasive Brain Imaging in Small Animal Stroke Models: MRI and PET

  2010cites this paper
• Current awareness in NMR in biomedicine.

  2009cites this paper
• Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat

  2008cites this paper
• ELECTIVE POTENTIATION OF THE METABOTROPIC GLUTAMATE ECEPTOR SUBTYPE 2 BLOCKS PHENCYCLIDINE-INDUCED YPERLOCOMOTION AND BRAIN ACTIVATION

  year unknowncites this paper